This topic contains a solution. Click here to go to the answer

Author Question: A system financed primarily through retrospective fee-for-service insurance reimbursement is: . a. ... (Read 89 times)

krzymel

  • Hero Member
  • *****
  • Posts: 548
A system financed primarily through retrospective fee-for-service insurance reimbursement is: .
 a. A closed system.
  b. An open-ended system.
  c. A cost-plus system
  d. An efficient system.
  e. Both b and c.

Question 2

What is the term for the contract that maximizes the principal's payoff subject to the constraint that the principal lacks the agent's private information?
 a. First best
  b. Second best
  c. Third best
  d. Pareto optimum



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

livaneabi

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

E

Answer to Question 2

b




krzymel

  • Member
  • Posts: 548
Reply 2 on: Jul 1, 2018
Great answer, keep it coming :)


Laurenleakan

  • Member
  • Posts: 309
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library